Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Sublingual Immunotherapy in Peanut-allergic Children (SLB)

This study has been completed.
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
Wesley Burks, MD, University of North Carolina, Chapel Hill Identifier:
First received: January 7, 2008
Last updated: October 20, 2016
Last verified: October 2016